Toboroz
INitiation and Titration of Guideline Directed Medical TheRApy in HearT Failure Cardiogenic Shock With ImpElla 5.5 for Cardiac Recovery
NCT06965504· Abiomed Inc.· Forrás
Contact: Laurie Machen
Toboroz
BOdygUardian MOnitoriNg for ReCurrencE of AF
NCT07671677· Heart Rhythm Clinical and Research Solutions, LLC· Forrás
Contact: Caitlin Phalunas
Toboroz
Comparison of Two Pulse Field Ablation Systems for AF Ablation
NCT07883629· Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)· Forrás
Contact: Heather McDonald, MHA, CCRC
Toboroz
Testing Addition of an Anti-cancer Drug, Vorasidenib to Temozolomide, After Radiation for Advanced Brain Cancer
NCT07215910· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Contact: John Herbst (principal investigator)
Fut, nem toboroz
An Open Label Extension (OLE) Study (Following Completion of CTQJ230A12301) to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)
NCT07517263· 3. fázis· Novartis Pharmaceuticals· Forrás
Toboroz
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
NCT07195734· 2. fázis· National Cancer Institute (NCI)· Forrás
Contact: Larisa Greenberg (principal investigator)
Toboroz
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
NCT07058012· 2. fázis· NSABP Foundation Inc· Forrás
Contact: Department of Site and Study Management (DSSM)
Toboroz
Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)
NCT07298473· Medtronic Cardiac Ablation Solutions· Forrás
Contact: Amit Thosani
Toboroz
The NAVIGATE-PCI Registry: A New Approach to VIew CT-derived Guidance Ahead of Stenting To Plan Efficient PCI
NCT07479433· HeartFlow, Inc.· Forrás
Contact: Ramzi Khalil, MD
Toboroz
Intervascular Post-Market Clinical Follow-Up (PMCF) Registry
NCT07322913· Intervascular· Forrás
Contact: Sheila Bernardini
Toboroz
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
NCT06524544· 3. fázis· National Cancer Institute (NCI)· Forrás
Contact: Alexander Helfand (principal investigator)
Toboroz
Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial
NCT06931340· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Contact: Shifeng S. Mao (principal investigator)
Toboroz
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With Relapsed Small Cell Lung Cancer (DLLEVATE)
NCT07218146· 3. fázis· Zai Lab (Shanghai) Co., Ltd.· Forrás
Toboroz
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's Disease
NCT07174310· 3. fázis· Hoffmann-La Roche· Forrás
Toboroz
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemoradiation and Pembrolizumab Maintenance Compared to Standard Chemoradiation With Pembrolizumab Followed by Pembrolizumab Maintenance in High-Risk Cervical Cancer
NCT07061977· 3. fázis· National Cancer Institute (NCI)· Forrás
Contact: Sarah M. Crafton (principal investigator)
Fut, nem toboroz
SPHERE Per-AF Post-Approval Study
NCT06858306· Medtronic Cardiac Ablation Solutions· Forrás
Toboroz
A Study of Tarlatamab in Combination With AB248 in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-311)
NCT07037758· 1. fázis· Amgen· Forrás
Toboroz
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
NCT06958328· 3. fázis· NRG Oncology· Forrás
Contact: Paul B. Renz (principal investigator)
Toboroz
Bachmann's Bundle Versus Right Atrial Appendage Pacing
NCT07874763· Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)· Forrás
Contact: Heather McDonald, MHA CCRC
Toboroz
Acoustic Cluster Therapy (ACT) With Chemotherapy for the Treatment of Locally Advanced Pancreatic Cancer
NCT06850623· 2. fázis· EXACT Therapeutics AS· Forrás
Contact: Paul Renz, DO
Toboroz
High-dose Prophylactic Gabapentin (HOPE) vs. Placebo to Prevent Opioid Use for Oral Mucositis Pain During Concurrent Chemoradiation for Head and Neck Cancer
NCT06992427· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Contact: Larisa Greenberg (principal investigator)
Toboroz
REdo tranScatheter Aortic Valve Replacement for Transcatheter aOrtic Valve failuRE
NCT06777368· Medtronic Cardiovascular· Forrás
Contact: Tracy Spirk
Toboroz
The PERSEVERE Study
NCT06588634· Inari Medical· Forrás
Contact: Mithun Chakravarthy, MD
Toboroz
Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure
NCT06526195· Abbott Medical Devices· Forrás
Contact: Laurie Machen
Fut, nem toboroz
Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of Care Docetaxel in Non-Small Cell Lung Cancer (ABBIL1TY NSCLC-06)
NCT06635824· 3. fázis· Genmab· Forrás
Toboroz
A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)
NCT06649110· 1/2. fázis· Novartis Pharmaceuticals· Forrás
Contact: Hayah Kassis-George (principal investigator)
Fut, nem toboroz
A Follow-up Study to Test Long-term Treatment With Nerandomilast in People With Pulmonary Fibrosis Who Took Part in a Previous Study With Nerandomilast
NCT06238622· 3. fázis· Boehringer Ingelheim· Forrás
Fut, nem toboroz
Detection and Classification of Cardiac Rhythm and Atrial Fibrillation Using a Finger-worn Ring
NCT06892938· Everbeat· Forrás
Fut, nem toboroz
Prospective Non-Interventional Study Comparing Osimertinib +/- Chemotherapy for EGFR-Mutated NSCLC Patients
NCT06538038· PrECOG, LLC.· Forrás
Toboroz
Measuring if Immunotherapy Plus Chemotherapy is Better Than Chemotherapy Alone for Patients With Aggressive Poorly Differentiated Sarcomas
NCT06422806· 3. fázis· National Cancer Institute (NCI)· Forrás
Contact: Larisa Greenberg (principal investigator)
Toboroz
A Study to Learn More About How Well Sevabertinib Works and How Safe it is Compared With Standard Treatment, in Participants Who Have Advanced Non-small Cell Lung Cancer (NSCLC) With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)
NCT06452277· 3. fázis· Bayer· Forrás
Toboroz
Androgen Suppression Combined With Nodal Irradiation and Dose Escalated Prostate Treatment
NCT06235697· 3. fázis· Canadian Cancer Trials Group· Forrás
Contact: Zachary Horne (principal investigator)
Meghívásos bevonás
A Registry Based Collaborative to Measure Efficiency, Effectiveness, and Safety of Farapulse PFA Technology for AF
NCT06335082· Heart Rhythm Clinical and Research Solutions, LLC· Forrás
Toboroz
Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
NCT05863195· 3. fázis· ECOG-ACRIN Cancer Research Group· Forrás
Contact: Patrick L. Wagner (principal investigator)
Fut, nem toboroz
REView of ProcEdural FactoRs and Outcomes After Atrial Fibrillation Ablation With Active Esophageal COOLing: A Sub-Study of the REAL AF Registry
NCT06354777· Heart Rhythm Clinical and Research Solutions, LLC· Forrás
Toboroz
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
NCT06035120· Pulmonx Corporation· Forrás
Contact: Paige Rutter
Toboroz
MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)
NCT06128629· 3. fázis· Intellia Therapeutics· Forrás
Contact: Trial Manager at Intellia
Toboroz
Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
NCT05929703· University of Michigan· Forrás
Contact: Lyn Weinberg, MD
Toboroz
ALLIANCE AVIV: Safety and Effectiveness of the SAPIEN X4 Transcatheter Heart Valve in Failing Aortic Bioprosthetic Valves
NCT05172973· Edwards Lifesciences· Forrás
Contact: Edwards THV Clinical Affairs
Toboroz
Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25
NCT05879926· 3. fázis· NRG Oncology· Forrás
Contact: Chirag S. Shah (principal investigator)
Toboroz
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial
NCT05673148· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás
Contact: Patrick L. Wagner (principal investigator)
Toboroz
Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab
NCT05812807· 3. fázis· Alliance for Clinical Trials in Oncology· Forrás
Contact: Chirag S. Shah (principal investigator)
Fut, nem toboroz
Assessment of Combined CCM and ICD Device in HFrEF
NCT05855135· Impulse Dynamics· Forrás
Toboroz
Comparison of the Outcomes of Single vs Multiple Arterial Grafts in Women
NCT04124120· Weill Medical College of Cornell University· Forrás
Contact: Scott Halbreiner, MD
Fut, nem toboroz
A Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local Therapies
NCT05794906· 3. fázis· Bayer· Forrás
Fut, nem toboroz
Testing the Addition of the AKT Inhibitor, Ipatasertib, to Treatment With the Hormonal Agent Megestrol Acetate for Recurrent or Metastatic Endometrial Cancers
NCT05538897· 1/2. fázis· National Cancer Institute (NCI)· Forrás
Toboroz
Vivistim Registry for Paired VNS Therapy (GRASP)
NCT05301140· MicroTransponder Inc.· Forrás
Contact: Alexander Whiting
Fut, nem toboroz
Testing the Use of Investigational Drugs Atezolizumab and/or Bevacizumab With or Without Standard Chemotherapy in the Second-Line Treatment of Advanced-Stage Head and Neck Cancers
NCT05063552· 2/3. fázis· National Cancer Institute (NCI)· Forrás
Fut, nem toboroz
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383· 3. fázis· Novartis Pharmaceuticals· Forrás
Fut, nem toboroz
Comparing Capecitabine and Temozolomide in Combination to Lutetium Lu 177 Dotatate in Patients With Advanced Pancreatic Neuroendocrine Tumors, the ComPareNET Trial
NCT05247905· 2. fázis· Alliance for Clinical Trials in Oncology· Forrás
Showing 50 of 119.